Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Targeting the PI3K/AKT Pathway and Fatty Acid Synthase in AL Amyloidosis: Mechanistic Insights and Therapeutic Implications

Tal Zvida-Bloch, Eli Muchtar, Mali Salmon-Divon, Angela Dispenzieri, Benjamin Bender, Adrian Duek, Merav Leiba, Moshe E Gatt, Ofer Shpilberg, Oshrat Hershkovitz-Rokah

Blood (2024) 144 (Supplement 1): 3288.

https://doi.org/10.1182/blood-2024-206682

Published: 2024

Journal Articles

Chronic Myeloid Leukemia Reduces Survival in Elderly Patients (age ≥ 75 years old): An International Multicenter Retrospective Study

Adi Shacham Abulafia, Alon Rozental, Erez Halperin, Chiya Leibovitch, Meirav Barzili, Maya Koren-Michowitz, Adrian Duek, Uri Rozovski, Pia Raanani

Blood (2023) 142 (Supplement 1): 6366.

https://doi.org/10.1182/blood-2023-189162

Published: 2023

Journal Articles

Non-Coding RNAs Regulate Novel Signaling Pathways in AL Amyloidosis That Are Targetable By BCL2, PI3K and MEK Inhibitors

Tal Zvida, Eli Muchtar, Mali Salmon-Divon, Angela Dispenzieri, Hila Fishov, Claudio Schneider, Benjamin Bender, Adrian Duek, Merav Leiba, Ofer Shpilberg, Oshrat Hershkovitz-Rokah

Blood (2022) 140 (Supplement 1): 7074–7075.

https://doi.org/10.1182/blood-2022-164964

Published: 2022

Journal Articles

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Luba Trakhtenbrot, PhD, Adrian Duek, MD, Ninette Amariglio, PhD, Abraham Avigdor, MD, Noam Benyamini, MD, Izhar Hardan, MD, Itay Zilbershatz, MD, Chezi Ganzel, MD, Olga Shvetz, MD, Ronit Leiba, PhD, Marina Izak, MD, Cohen Ziv, Ba, Gabriela Rozic, PhD, Arnon Nagler, MD, Merav Leiba

Blood (2017) 130 (Supplement 1): 5368.

https://doi.org/10.1182/blood.V130.Suppl_1.5368.5368

Published: 2017

Journal Articles

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Ohad Benjamini, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Meirav Kedmi, MD, Adrian Duek, MD, Drorit Merkel, MD, Merav Leiba, MD, Ivetta Danylesko, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, Yulia Volchek, MD

Blood (2016) 128 (22): 5429.

https://doi.org/10.1182/blood.V128.22.5429.5429

Published: 2016

Journal Articles

Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2 -V617F mouse model of MPN

Jean Grisouard, Takafumi Shimizu, Adrian Duek, Lucia Kubovcakova, Hui Hao-Shen, Stephan Dirnhofer, Radek C. Skoda

Blood (2015) 125 (13): 2131–2140.

https://doi.org/10.1182/blood-2014-08-594572

Published: 2015

Includes: Supplemental data

Journal Articles

Ruxolitinib Treatment for Myelofibrosis: Efficacy and Tolerability in a Real-World Setting

Martin H. Ellis, MD, Noa Lavi, MD, Elena Mishchenko, MD, Najib Dally, MD, David Lavie, MD, Anna Courevitch, MD, Odit Gutwein, MD, Shlomo Bulvik, MD, Andrei Braester, MD, Evgeni Chubar, MD, Sigal Tavor, MD, Adrian Duek, MD, Ilya Kirgner, MD, Maya Koren-Michowitz, MD

Blood (2014) 124 (21): 1830.

https://doi.org/10.1182/blood.V124.21.1830.1830

Published: 2014

Journal Articles

Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2 -V617F–driven mouse model of MPNs

Adrian Duek, Pontus Lundberg, Takafumi Shimizu, Jean Grisouard, Axel Karow, Lucia Kubovcakova, Hui Hao-Shen, Stephan Dirnhofer, Radek C. Skoda

Blood (2014) 123 (25): 3943–3950.

https://doi.org/10.1182/blood-2013-07-514208

Published: 2014

Journal Articles

Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia

Jean Grisouard, Mario Ojeda-Uribe, Renate Looser, Hui Hao-Shen, Pontus Lundberg, Adrian Duek, Eric Jeandidier, Axel Karow, Radek C. Skoda

Blood (2013) 122 (22): 3694–3696.

https://doi.org/10.1182/blood-2013-07-516385

Published: 2013

Journal Articles

Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab/Chemotherapy Treatment

Kalman Filanovsky, MD, Lev Shvidel, MD, Mordechai Shtalrid, MD, Michal Haran, MD, Adrian Duek, MD, Alain Berrebi

Blood (2007) 110 (11): 1288.

https://doi.org/10.1182/blood.V110.11.1288.1288

Published: 2007

Journal Articles

The Jak2-Inhibitor AG409 Affects Survival of BFU-E and CFU-GM of Myeloproliferative Disorder Cells Carrying the JAK2 V617F Mutation.

Adrian Duek, MD, Ina Lichman, MD, Mordejai Shtalrid, MD, Alain Berrebi

Blood (2006) 108 (11): 4907.

https://doi.org/10.1182/blood.V108.11.4907.4907

Published: 2006

Journal Articles

Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement.

Michal Z. Haran, MD, Reshmi Parameswaran, Edit Feldberg, MD, Mina Fogel, PhD, Monica Huszar, MD, Alain Berrebi, MD, Mordechai Shtalrid, MD, Lev Shvidel, MD, Adrian Duek, MD, Merav Leiba, PhD, Arnon Nagler, MD, Dov Zipori, PhD

Blood (2005) 106 (11): 4669.

https://doi.org/10.1182/blood.V106.11.4669.4669

Published: 2005

Journal Articles

Epidemiology and Features of Multiple Myeloma in a Cohort of 110 Patients from a Central Area of Israel.

Adrian Duek, MD, Michal Haran, MD, Lev Shvidel, MD, Mordechai Shtalrid, M.D, Erica Sigler, MD, Alain Berrebi, M.D.

Blood (2005) 106 (11): 5169.

https://doi.org/10.1182/blood.V106.11.5169.5169

Published: 2005

Journal Articles

Chronic Lymphocytic Leukemia Associated with Autoimmune Diseases Often Discloses Activated Phenotype Pattern.

Adrian Duek, MD, Lev Shvidel, MD, Alain Berrebi, Osnat Bairey, MD, Andre Braester, MD, Naomi Rahimi-Levene, MD

Blood (2004) 104 (11): 4802.

https://doi.org/10.1182/blood.V104.11.4802.4802

Published: 2004

NARROW

Targeting the PI3K/AKT Pathway and Fatty Acid Synthase in AL Amyloidosis: Mechanistic Insights and Therapeutic Implications

Chronic Myeloid Leukemia Reduces Survival in Elderly Patients (age ≥ 75 years old): An International Multicenter Retrospective Study

Non-Coding RNAs Regulate Novel Signaling Pathways in AL Amyloidosis That Are Targetable By BCL2, PI3K and MEK Inhibitors

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2 -V617F mouse model of MPN

Ruxolitinib Treatment for Myelofibrosis: Efficacy and Tolerability in a Real-World Setting

Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2 -V617F–driven mouse model of MPNs

Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia

Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab/Chemotherapy Treatment

The Jak2-Inhibitor AG409 Affects Survival of BFU-E and CFU-GM of Myeloproliferative Disorder Cells Carrying the JAK2 V617F Mutation.

Down-Regulation of Activin A by Lymphoma: A Possible Mechanism of Bone Marrow Involvement.

Epidemiology and Features of Multiple Myeloma in a Cohort of 110 Patients from a Central Area of Israel.

Chronic Lymphocytic Leukemia Associated with Autoimmune Diseases Often Discloses Activated Phenotype Pattern.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only